Ianthe Pitout

This inventor holds 1 USPTO granted patent. Top assignee: Pyc Therapeutics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ianthe Pitout. Retrieved from https://idiyas.com/inventor/ianthe-pitout-of8sk9y7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ianthe Pitout: Innovator in Optic Atrophy Treatment

Introduction

Ianthe Pitout is a notable inventor recognized for her contributions to the field of medical treatments. She has developed a significant patent that addresses the treatment of optic atrophy. Her work is crucial in advancing therapeutic options for individuals affected by this condition.

Latest Patents

Ianthe holds a patent for the "Treatment of Optic Atrophy." This innovation represents her commitment to improving patient outcomes and enhancing the understanding of optic nerve health. She has successfully secured 1 patent in this area.

Career Highlights

Ianthe is currently associated with Pyc Therapeutics Limited, a company dedicated to pioneering therapeutic solutions. Her role at the company allows her to leverage her expertise in developing innovative treatments.

Collaborations

Ianthe collaborates with talented individuals such as Janya Grainok and Sasiwimon Utama. These partnerships enhance her research and development efforts, fostering a collaborative environment that drives innovation.

Conclusion

Ianthe Pitout's work in the treatment of optic atrophy exemplifies her dedication to medical innovation. Her contributions are paving the way for new therapeutic approaches that can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…